Prospective Clinical Utility Study to Assess the Impact of Decipher on Treatment Decisions After Surgery

NACompletedINTERVENTIONAL
Enrollment

286

Participants

Timeline

Start Date

May 31, 2014

Primary Completion Date

February 1, 2017

Study Completion Date

February 1, 2017

Conditions
Prostate Cancer
Interventions
OTHER

Decipher

Trial Locations (19)

17604

Lancaster Urology, Lancaster

19107

Thomas Jefferson University, Philadelphia

19111

Fox Chase Cancer Center, Philadelphia

23235

Virginia Urology, Richmond

28054

Carolina Urology Partners, Gastonia

33016

Urological Research Network, Hialeah

33101

University of Miami Miller School of Medicine, Miami

33805

Lakeland Regional Health Systems, Lakeland

49546

Spectrum Health Medical Group, Grand Rapids

80045

University of Colorado, Denver Medical Campus, Aurora

80211

The Urology Center of Colorado, Denver

84112

Huntsman Cancer Hospital, Salt Lake City

90048

Cedars-Sinai Medical Center, Los Angeles

99503

Alaska Urology Institute Alaska Clinical Research Center, Anchorage

02115

Brigham and Women's Hospital, Boston

08043

Delaware Valley Urology, LLC, Voorhees Township

753910-9110

UT Southwestern Medical Center, Dallas

05401

University of Vermont Medical Center, Burlington

Unknown

University of Washington, Seattle

Sponsors
All Listed Sponsors
collaborator

Society of Urologic Oncology (SUO)

UNKNOWN

lead

GenomeDx Biosciences Corp

INDUSTRY